Use of Idarucizumab to reverse the anticoagulant effect of dabigatran in cardiac transplant surgery. A multicentric experience in Spain
Journal article published in 2019 by
Maria G. Crespo‐Leiro 
,
Raquel López‐Vilella,
Amador López Granados,
Sonia Mirabet‐Pérez ,
Carles Díez‐López,
Eduardo Barge‐Caballero,
Javier Segovia‐Cubero,
Francisco González‐Vilchez,
Diego Rangel‐Sousa,
Teresa Blasco‐Peiró,
Luis Fuente‐Galán,
Beatriz Díaz‐Molina,
Eduardo Zatarain‐Nicolás,
Francisco Carrasco Ávalos,
Luis Almenar‐Bonet
,
Raquel López‐Vilella,
Amador López Granados,
Sonia Mirabet‐Pérez ,
Carles Díez‐López,
Eduardo Barge‐Caballero,
Javier Segovia‐Cubero,
Francisco González‐Vilchez,
Diego Rangel‐Sousa,
Teresa Blasco‐Peiró,
Luis Fuente‐Galán,
Beatriz Díaz‐Molina,
Eduardo Zatarain‐Nicolás,
Francisco Carrasco Ávalos,
Luis Almenar‐Bonet
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 